Psychiatry MMC | A peer-reviewed journal providing evidence-based information to practicing clinicians

Site Search


Free NEI Membership Offer

Receive a free two-month membership term to NEI when you register on Psychiatry (Edgemont)'s website!

Click here for more info

Join our Facebook Group


Elizabeth Klumpp's Facebook Profile

Follow Us on Twitter

Follow Psych_Edgemont on Twitter

The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part I—Statistics and the Case for the “Greater Good”

March 2009

by David Feifel, MD, PhD

Dr. Feifel is Professor, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California.

This is protected content.
:
:
Content Protected by SmartLogix

Popularity: unranked [?]

Share and Enjoy:
  • HealthRanker
  • Google Bookmarks
  • LinkedIn
  • Facebook
  • Digg
  • Yahoo! Buzz
  • StumbleUpon
  • del.icio.us
  • ThisNext

Posted in Research to Practice | No Comments »

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.